LongILMNJun 2026
Illumina, Inc.
Diamond Hill views Illumina as the leading producer of next-generation sequencing systems used in DNA research and increasingly in cancer diagnosis and treatment. The investment…
ILMN
2 published ideas on Illumina, Inc. across 2 funds — 2 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Illumina, Inc.: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Diamond Hill views Illumina as the leading producer of next-generation sequencing systems used in DNA research and increasingly in cancer diagnosis and treatment. The investment…
Illumina is the leading producer of next-generation sequencing systems used to sequence DNA for research and increasingly for cancer diagnosis and treatment. Shares strengthened…